Literature DB >> 26153623

Laryngeal adenoid cystic carcinoma: A population-based perspective.

Pariket M Dubal1, Peter F Svider2, Adam J Folbe2, Ho-Sheng Lin2,3, Richard C Park1, Soly Baredes1,4, Jean Anderson Eloy1,4,5,6.   

Abstract

OBJECTIVES/HYPOTHESIS: Adenoid cystic carcinoma (ACC) occurs infrequently in the larynx. Consequently, no large samples describing its clinical behavior are available in the literature. Our objective was to use a nationally representative population-based resource to evaluate clinical behavior, patient demographics, and outcomes among patients diagnosed with laryngeal ACC (LACC). STUDY
DESIGN: Retrospective database analysis.
METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results database was analyzed for patients diagnosed with LACC between 1973 and 2011. Patient demographics, incidence, treatment, and survival between LACC and other laryngeal malignancies were compared.
RESULTS: Of 69 LACC patients, 63.8% were female, 78.2% Caucasian, and the median age was 54 years. LACC patients were much more likely to have subglottic lesions (44.9%) than individuals with other malignancies (1.6%). The incidence of LACC was 0.005/100,000 individuals. The majority of patients with LACC harbored T4 lesions at initial diagnosis, although 87.9% had N0 disease, and only 6.1% had distant metastasis at diagnosis. Disease-specific survival (DSS) was greater at 1 year for LACC compared to other laryngeal malignancies, but not at 5 or 10 years. Five-year DSS was greater for LACC patients who underwent surgery versus those who did not undergo surgery.
CONCLUSIONS: This analysis notes that LACC has a low incidence with no significant change in incidence over the study period. Compared to other laryngeal malignancies, LACC has a female preponderance, is much more common in the subglottis, presents at a younger age, and more often presents with T4 disease. Surgery was noted to confer a survival advantage in LACC. LEVEL OF EVIDENCE: 4.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Adenoid cystic carcinoma; Epidemiology; Surveillance; and End Results; disease-specific survival; incidence; laryngeal adenoid cystic carcinoma; laryngeal cancer; population-based; survival

Mesh:

Year:  2015        PMID: 26153623     DOI: 10.1002/lary.25448

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Laryngeal adenoid cystic carcinoma: a rare case report.

Authors:  Hadi Eslami Aliabadi; Shahriar Dabiri; Soheil Motamed
Journal:  Int J Clin Exp Pathol       Date:  2022-02-15

Review 2.  Cervical Lymph Node Metastasis in Adenoid Cystic Carcinoma of the Larynx: A Collective International Review.

Authors:  Andrés Coca-Pelaz; Leon Barnes; Alessandra Rinaldo; Antonio Cardesa; Jatin P Shah; Juan P Rodrigo; Carlos Suárez; Jean Anderson Eloy; Justin A Bishop; Kenneth O Devaney; Lester D R Thompson; Bruce M Wenig; Primož Strojan; Marc Hamoir; Patrick J Bradley; Douglas R Gnepp; Carl E Silver; Pieter J Slootweg; Asterios Triantafyllou; Vincent Vander Poorten; Michelle D Williams; Alena Skálová; Henrik Hellquist; Afshin Teymoortash; Jesus E Medina; K Thomas Robbins; Karen T Pitman; Luiz P Kowalski; Remco de Bree; William M Mendenhall; Robert P Takes; Alfio Ferlito
Journal:  Adv Ther       Date:  2016-03-19       Impact factor: 3.845

Review 3.  Rare location of head and neck adenoid cystic carcinoma.

Authors:  Asmaa Naim; Amal Hajjij; Faycal Abbad; Amal Rami; Mustapha Essaadi
Journal:  Pan Afr Med J       Date:  2019-09-16

4.  Surgical management and oncological outcome of non-squamous cell carcinoma of the larynx: a bicentric study.

Authors:  Andrea Iandelli; Francesco Missale; Cesare Piazza; Giorgio Peretti; Andrea Laborai; Marta Filauro; Filippo Marchi; Francesca Del Bon; Pietro Perotti; Giampiero Parrinello
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-24       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.